Pharma repurposing: Old drugs, new tricks
The development of new uses for existing drugs raises complex questions about patent law, regulation, economics and health policy. James Nurton reports from a recent conference hosted by UCL and Georgetown Law School
The story of thalidomide has three chapters. The first chapter ended in tragedy. The drug was developed by German company Grünenthal in the 1950s to treat morning sickness in pregnant women. The results were devastating: 12,000 children were born with...
Please log in
to read the rest of this article. New to Managing Intellectual Property?
Take advantage of free access to up to 5 articles on Managing IP and become a member today. It’s free to join and the benefits start straight away.
Please make sure you log in to read the rest of the article.
Join us nowGain FREE access to up to five free articles when you register now.